nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—osteoarthritis	0.0141	1	CrCbGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.00354	0.00359	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.00346	0.00351	CbGpPWpGaD
Dinoprostone—HPGDS—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00335	0.0034	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—MCF2L—osteoarthritis	0.00333	0.00338	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet degranulation—FN1—osteoarthritis	0.00332	0.00337	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—MCF2L—osteoarthritis	0.00326	0.00331	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—MCF2L—osteoarthritis	0.00326	0.00331	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00323	0.00328	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PTGES—osteoarthritis	0.00318	0.00322	CbGpPWpGaD
Dinoprostone—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—osteoarthritis	0.00316	0.00321	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IHH—osteoarthritis	0.00315	0.0032	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MCF2L—osteoarthritis	0.00315	0.0032	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IHH—osteoarthritis	0.00302	0.00307	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—MCF2L—osteoarthritis	0.00302	0.00307	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—MCF2L—osteoarthritis	0.00296	0.003	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IHH—osteoarthritis	0.00296	0.003	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—MCF2L—osteoarthritis	0.00296	0.003	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IHH—osteoarthritis	0.00296	0.003	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet degranulation—IGF1—osteoarthritis	0.00291	0.00295	CbGpPWpGaD
Dinoprostone—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	0.00277	0.00281	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.00272	0.00276	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00269	0.00273	CbGpPWpGaD
Dinoprostone—CYP11A1—Corticotropin-releasing hormone—CXCL8—osteoarthritis	0.00264	0.00268	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.0026	0.00263	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IHH—osteoarthritis	0.00259	0.00262	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MCF2L—osteoarthritis	0.00259	0.00262	CbGpPWpGaD
Dinoprostone—CYP1A2—Phase II conjugation—GSTO1—osteoarthritis	0.00254	0.00258	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00251	0.00254	CbGpPWpGaD
Dinoprostone—HPGDS—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.00242	0.00246	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—FMOD—osteoarthritis	0.00241	0.00244	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MCF2L—osteoarthritis	0.00239	0.00242	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IHH—osteoarthritis	0.00239	0.00242	CbGpPWpGaD
Dinoprostone—PTGER4—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00238	0.00241	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00237	0.0024	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—HSPA5—osteoarthritis	0.00236	0.00239	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—COL9A2—osteoarthritis	0.00231	0.00235	CbGpPWpGaD
Dinoprostone—PTGER3—G alpha (i) signalling events—CXCL8—osteoarthritis	0.00226	0.0023	CbGpPWpGaD
Dinoprostone—HPGDS—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00226	0.00229	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—COL9A1—osteoarthritis	0.00225	0.00228	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TIMP1—osteoarthritis	0.00224	0.00228	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—GSTO1—osteoarthritis	0.00224	0.00227	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—BGN—osteoarthritis	0.00217	0.0022	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IHH—osteoarthritis	0.00215	0.00218	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00214	0.00217	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—CAMK2B—osteoarthritis	0.00206	0.00209	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00203	0.00206	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—FMOD—osteoarthritis	0.00202	0.00205	CbGpPWpGaD
Dinoprostone—CYP11A1—Corticotropin-releasing hormone—TGFB1—osteoarthritis	0.00197	0.002	CbGpPWpGaD
Dinoprostone—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00195	0.00198	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—CAMK2B—osteoarthritis	0.00192	0.00195	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—COL9A2—osteoarthritis	0.0019	0.00193	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—COL9A1—osteoarthritis	0.00184	0.00187	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.00183	0.00186	CbGpPWpGaD
Dinoprostone—PTGER4—GPCR ligand binding—CXCL8—osteoarthritis	0.00181	0.00183	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—MMP3—osteoarthritis	0.00181	0.00183	CbGpPWpGaD
Dinoprostone—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.0018	0.00183	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IHH—osteoarthritis	0.00179	0.00181	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MCF2L—osteoarthritis	0.00179	0.00181	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—FMOD—osteoarthritis	0.00177	0.00179	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—COL9A2—osteoarthritis	0.00175	0.00178	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MCF2L—osteoarthritis	0.00175	0.00177	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IHH—osteoarthritis	0.00175	0.00177	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MCF2L—osteoarthritis	0.00175	0.00177	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IHH—osteoarthritis	0.00175	0.00177	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet degranulation—TGFB1—osteoarthritis	0.00174	0.00177	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—COL9A1—osteoarthritis	0.0017	0.00173	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.00169	0.00172	CbGpPWpGaD
Dinoprostone—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	0.00166	0.00168	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.00166	0.00168	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGES—osteoarthritis	0.00164	0.00167	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFBI—osteoarthritis	0.0016	0.00162	CbGpPWpGaD
Dinoprostone—ABCC5—NRF2 pathway—TGFB1—osteoarthritis	0.00155	0.00158	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—BMP2—osteoarthritis	0.00154	0.00156	CbGpPWpGaD
Dinoprostone—CYP1A2—Biological oxidations—GSTO1—osteoarthritis	0.00149	0.00151	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR ligand binding—CXCL8—osteoarthritis	0.00149	0.00151	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—MMP3—osteoarthritis	0.00148	0.0015	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.00147	0.00149	CbGpPWpGaD
Dinoprostone—CYP1A2—Metapathway biotransformation—GSTO1—osteoarthritis	0.00147	0.00149	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGES—osteoarthritis	0.00144	0.00146	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HSPA5—osteoarthritis	0.0014	0.00142	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.0014	0.00142	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—MMP1—osteoarthritis	0.0014	0.00142	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—GSTO1—osteoarthritis	0.00138	0.0014	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR ligand binding—CXCL8—osteoarthritis	0.00137	0.00139	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—MMP3—osteoarthritis	0.00137	0.00139	CbGpPWpGaD
Dinoprostone—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00135	0.00137	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—BGN—osteoarthritis	0.00134	0.00136	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TIMP1—osteoarthritis	0.00134	0.00136	CbGpPWpGaD
Dinoprostone—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00132	0.00134	CbGpPWpGaD
Dinoprostone—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00132	0.00134	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—COL9A2—osteoarthritis	0.00131	0.00133	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—FMOD—osteoarthritis	0.00129	0.00131	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.00129	0.00131	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—COL9A2—osteoarthritis	0.00128	0.0013	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—COL9A2—osteoarthritis	0.00128	0.0013	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—FN1—osteoarthritis	0.00127	0.00129	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—COL9A1—osteoarthritis	0.00127	0.00129	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—BMP2—osteoarthritis	0.00126	0.00128	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—COL9A1—osteoarthritis	0.00125	0.00126	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—COL9A1—osteoarthritis	0.00125	0.00126	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	0.00119	0.00121	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—FMOD—osteoarthritis	0.00117	0.00119	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—BMP2—osteoarthritis	0.00117	0.00118	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GSTO1—osteoarthritis	0.00116	0.00117	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—BGN—osteoarthritis	0.00112	0.00114	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—IGF1—osteoarthritis	0.00112	0.00113	CbGpPWpGaD
Dinoprostone—CYP1A2—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00111	0.00113	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—FMOD—osteoarthritis	0.00111	0.00112	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.00111	0.00112	CbGpPWpGaD
Dinoprostone—ABCC4—NRF2 pathway—TGFB1—osteoarthritis	0.00108	0.00109	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MMP3—osteoarthritis	0.00107	0.00108	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGES—osteoarthritis	0.00106	0.00107	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR ligand binding—CXCL8—osteoarthritis	0.00103	0.00104	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—MMP3—osteoarthritis	0.00102	0.00104	CbGpPWpGaD
Dinoprostone—PTGER4—GPCR downstream signaling—CXCL8—osteoarthritis	0.00102	0.00104	CbGpPWpGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.00102	0.00104	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—FMOD—osteoarthritis	0.00101	0.00103	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GSTO1—osteoarthritis	0.00101	0.00103	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR ligand binding—CXCL8—osteoarthritis	0.001	0.00102	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR ligand binding—CXCL8—osteoarthritis	0.001	0.00102	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—MMP3—osteoarthritis	0.001	0.00102	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—MMP3—osteoarthritis	0.001	0.00102	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.001	0.00101	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—BGN—osteoarthritis	0.000983	0.000997	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SMAD3—osteoarthritis	0.000965	0.000979	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGES—osteoarthritis	0.000954	0.000968	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—FMOD—osteoarthritis	0.000946	0.000959	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—CXCL8—osteoarthritis	0.000928	0.000942	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGES—osteoarthritis	0.000903	0.000915	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MMP3—osteoarthritis	0.000876	0.000888	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—BMP2—osteoarthritis	0.000872	0.000885	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000859	0.000872	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—BMP2—osteoarthritis	0.000854	0.000866	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—BMP2—osteoarthritis	0.000854	0.000866	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—CXCL8—osteoarthritis	0.000839	0.000851	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—MMP1—osteoarthritis	0.000832	0.000844	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGES—osteoarthritis	0.000827	0.000839	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—LEP—osteoarthritis	0.000825	0.000837	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00081	0.000822	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MMP3—osteoarthritis	0.000808	0.00082	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000802	0.000814	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000802	0.000814	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SMAD3—osteoarthritis	0.000793	0.000804	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—ESR1—osteoarthritis	0.000788	0.000799	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—FN1—osteoarthritis	0.000778	0.000789	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—CXCL8—osteoarthritis	0.000775	0.000786	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000773	0.000784	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGES—osteoarthritis	0.000771	0.000782	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—CXCL8—osteoarthritis	0.000762	0.000773	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—FN1—osteoarthritis	0.000759	0.00077	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSTO1—osteoarthritis	0.000744	0.000754	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SMAD3—osteoarthritis	0.000732	0.000742	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—BGN—osteoarthritis	0.00072	0.00073	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—CXCL8—osteoarthritis	0.000703	0.000714	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IGF1—osteoarthritis	0.000682	0.000692	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—LEP—osteoarthritis	0.000678	0.000687	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTO1—osteoarthritis	0.000672	0.000682	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TGFB1—osteoarthritis	0.000669	0.000678	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—IGF1—osteoarthritis	0.000665	0.000674	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SMAD3—osteoarthritis	0.000658	0.000667	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—BGN—osteoarthritis	0.000651	0.00066	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ESR1—osteoarthritis	0.000647	0.000656	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—FN1—osteoarthritis	0.000639	0.000648	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTO1—osteoarthritis	0.000636	0.000645	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000634	0.000643	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—LEP—osteoarthritis	0.000625	0.000634	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PTGS2—osteoarthritis	0.000623	0.000632	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—BGN—osteoarthritis	0.000616	0.000625	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP3—osteoarthritis	0.000604	0.000613	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ESR1—osteoarthritis	0.000597	0.000606	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP3—osteoarthritis	0.000592	0.0006	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP3—osteoarthritis	0.000592	0.0006	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—FN1—osteoarthritis	0.00059	0.000598	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTO1—osteoarthritis	0.000583	0.000591	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—CXCL8—osteoarthritis	0.000579	0.000588	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—CXCL8—osteoarthritis	0.000567	0.000575	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—CXCL8—osteoarthritis	0.000567	0.000575	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—BGN—osteoarthritis	0.000564	0.000572	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IGF1—osteoarthritis	0.00056	0.000568	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CXCL8—osteoarthritis	0.000548	0.000556	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SMAD3—osteoarthritis	0.000547	0.000555	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTO1—osteoarthritis	0.000543	0.000551	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SMAD3—osteoarthritis	0.000535	0.000543	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SMAD3—osteoarthritis	0.000535	0.000543	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—CXCL8—osteoarthritis	0.000526	0.000534	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—BGN—osteoarthritis	0.000526	0.000534	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—IL6—osteoarthritis	0.000521	0.000529	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IGF1—osteoarthritis	0.000517	0.000524	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—CXCL8—osteoarthritis	0.000515	0.000522	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—CXCL8—osteoarthritis	0.000515	0.000522	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MMP9—osteoarthritis	0.000496	0.000503	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—LEP—osteoarthritis	0.000468	0.000474	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000465	0.000472	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—LEP—osteoarthritis	0.000458	0.000464	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—LEP—osteoarthritis	0.000458	0.000464	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CXCL8—osteoarthritis	0.00045	0.000457	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ESR1—osteoarthritis	0.000446	0.000453	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FMOD—osteoarthritis	0.000442	0.000449	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—FN1—osteoarthritis	0.000441	0.000447	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ESR1—osteoarthritis	0.000437	0.000443	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ESR1—osteoarthritis	0.000437	0.000443	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—FN1—osteoarthritis	0.000432	0.000438	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—FN1—osteoarthritis	0.000432	0.000438	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL6—osteoarthritis	0.000428	0.000434	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00042	0.000426	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CXCL8—osteoarthritis	0.000416	0.000422	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TGFB1—osteoarthritis	0.000409	0.000415	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MMP9—osteoarthritis	0.000407	0.000413	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TGFB1—osteoarthritis	0.000399	0.000404	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000398	0.000403	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL6—osteoarthritis	0.000395	0.000401	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IGF1—osteoarthritis	0.000386	0.000392	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTGS2—osteoarthritis	0.000385	0.000391	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IGF1—osteoarthritis	0.000378	0.000384	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IGF1—osteoarthritis	0.000378	0.000384	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MMP9—osteoarthritis	0.000376	0.000381	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGES—osteoarthritis	0.000361	0.000366	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFB1—osteoarthritis	0.000336	0.00034	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—osteoarthritis	0.000323	0.000327	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCL8—osteoarthritis	0.000311	0.000315	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—osteoarthritis	0.00031	0.000314	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—osteoarthritis	0.000308	0.000312	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCL8—osteoarthritis	0.000304	0.000309	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCL8—osteoarthritis	0.000304	0.000309	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—osteoarthritis	0.000295	0.0003	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—osteoarthritis	0.000289	0.000293	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—osteoarthritis	0.000289	0.000293	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—osteoarthritis	0.000282	0.000287	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—osteoarthritis	0.000281	0.000285	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—osteoarthritis	0.000278	0.000282	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—osteoarthritis	0.000275	0.000279	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—osteoarthritis	0.000275	0.000279	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTO1—osteoarthritis	0.000254	0.000258	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—osteoarthritis	0.000253	0.000257	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—BGN—osteoarthritis	0.000246	0.00025	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—osteoarthritis	0.000233	0.000237	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—osteoarthritis	0.000232	0.000235	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—osteoarthritis	0.000227	0.00023	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—osteoarthritis	0.000227	0.00023	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—osteoarthritis	0.00021	0.000213	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—osteoarthritis	0.000207	0.00021	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—osteoarthritis	0.000187	0.00019	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—osteoarthritis	0.000177	0.00018	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—osteoarthritis	0.000175	0.000177	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—osteoarthritis	0.000171	0.000173	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—osteoarthritis	0.000171	0.000173	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—osteoarthritis	0.000162	0.000165	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000159	0.000161	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—osteoarthritis	0.000151	0.000153	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—osteoarthritis	7.08e-05	7.18e-05	CbGpPWpGaD
